Literature DB >> 26527567

Pregnancy outcome of 149 pregnancies in women with epilepsy: Experience from a tertiary care hospital.

Ozhan Ozdemir1, Mustafa Erkan Sari1, Aslihan Kurt1, Vefa Selimova Sakar1, Cemal Resat Atalay1.   

Abstract

INTRODUCTION: Epilepsy has a prevalence of 1.65% in adults, and every 1 in 200 pregnancies encounters its complications. We aimed to present the existing condition of and our experience with epileptic pregnant women for whom the prepregnancy counseling is inadequate in Turkey.
METHODS: We evaluated 149 epileptic pregnant women between March 2009 and January 2015. Demographic features of the patients, along with type and duration of epileptic seizure, time of diagnosis, date of last seizure prior to pregnancy, number and duration of seizures during pregnancy, type of AEDs, result and week of termination of pregnancy, and birth weight were registered, and also, we evaluated perinatal complications and fetal malformations.
RESULTS: Mean age of the patients was 27.12 ± 5.4 years, and mean duration from the diagnosis of epilepsy to pregnancy was 9.68 ± 5.91 years. Twenty-seven (18.12%) and 101 (67.78%) patients had polytherapy and monotherapy, respectively. We observed epileptic seizures in 103 (69.12%) patients during pregnancy, and seizures mostly occurred in the first and third trimesters. Forty-one (39.80%) patients had seizures in all three trimesters. Forty-two (28.18%) patients among all patients who had seizures during pregnancy had 5 or more seizures. Major malformations, namely, cleft lip and palate, ventriculoseptal defect, and spina bifida were observed in the patients. Mean birth week was 38.43 ± 1.68 weeks, and mean birth weight was 2965.31 ± 453.94 grams. Twenty-two patients had normal spontaneous vaginal delivery whereas 118 patients had cesarean section.
CONCLUSIONS: Pregnant women with epilepsy have their own risks. These women should be followed by experienced obstetricians and neurologists during their pregnancies. Appropriate management and follow-up lead to good results almost the same as general population.

Entities:  

Keywords:  hospital mortality; redo cardiac surgery; risk factors

Year:  2015        PMID: 26527567      PMCID: PMC4609022          DOI: 10.1556/1646.7.2015.3.4

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  20 in total

1.  Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs.

Authors:  Christina Pilo; Katarina Wide; Birger Winbladh
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

2.  Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.

Authors:  Katriina Viinikainen; Seppo Heinonen; Kai Eriksson; Reetta Kälviäinen
Journal:  Epilepsia       Date:  2006-01       Impact factor: 5.864

3.  In utero antiepileptic drug exposure: fetal death and malformations.

Authors:  K J Meador; G A Baker; R H Finnell; L A Kalayjian; J D Liporace; D W Loring; G Mawer; P B Pennell; J C Smith; M C Wolff
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

Review 4.  Antiepileptic drugs.

Authors:  M J Brodie; M A Dichter
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

Review 5.  Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?

Authors:  Naghme Adab
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.

Authors: 
Journal:  Neurology       Date:  2005-12-28       Impact factor: 9.910

7.  The longer term outcome of children born to mothers with epilepsy.

Authors:  N Adab; U Kini; J Vinten; J Ayres; G Baker; J Clayton-Smith; H Coyle; A Fryer; J Gorry; J Gregg; G Mawer; P Nicolaides; L Pickering; L Tunnicliffe; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

8.  Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study.

Authors:  D Kjaer; E Horvath-Puhó; J Christensen; M Vestergaard; A E Czeizel; H T Sørensen; J Olsen
Journal:  BJOG       Date:  2007-11-12       Impact factor: 6.531

Review 9.  Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age.

Authors:  D Lindhout; J G Omtzigt
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

10.  Epilepsy and postpartum depression.

Authors:  Katherine Turner; Ada Piazzini; Albertina Franza; Anna Maria Marconi; Raffaele Canger; Maria Paola Canevini
Journal:  Epilepsia       Date:  2009-01       Impact factor: 5.864

View more
  4 in total

Review 1.  Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children.

Authors:  Zixuan Wang; Phoebe W H Ho; Michael T H Choy; Ian C K Wong; Ruth Brauer; Kenneth K C Man
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

2.  Obstetric outcomes in pregnant women with seizure disorder: A hospital-based, longitudinal study.

Authors:  Tarang Preet Kaur; Latika Sahu; Asmita M Rathore; Sangeeta Bhasin
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

3.  The impact of maternal epilepsy on delivery and neonatal outcomes.

Authors:  Shahla Melikova; Hijran Bagirova; Sharif Magalov
Journal:  Childs Nerv Syst       Date:  2019-11-30       Impact factor: 1.475

Review 4.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.